About Unitab Pharmaceuticals Private Limited
Data last updated:
Unitab Pharmaceuticals Private Limited is a private limited company based in Varanasi, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 November 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U52100UP2011PTC047423. Its GSTIN is 09AABCU3713A1ZT (Uttar Pradesh).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anjana Gupta and Manoj Kumar Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 203 Industrial Estate Maheshpur Lahartara, Varanasi, Uttar Pradesh, India – 221106.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.08 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹1,177 (net margin 0%) and EBITDA of ₹4,277 (EBITDA margin 0%). Revenue has grown at a compounded annual rate (CAGR) of 163% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unitab.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address203 Industrial Estate Maheshpur Lahartara, Varanasi, Uttar Pradesh, India – 221106
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Unitab Pharmaceuticals Private Limited
The main business activity of Unitab Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Unitab Pharmaceuticals Private Limited FY 2025 filings available
Unitab Pharmaceuticals Private Limited reported revenue of ₹1.08 Cr (down 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Unitab Pharmaceuticals Private Limited
Revenue fell 7% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 163%. EBITDA fell 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Unitab Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4,277 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1,177 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Unitab Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Unitab Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Unitab Pharmaceuticals Private Limited
Unitab Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anjana Gupta | Director | 13 Feb 2014 | 12 Years 8 Months | Current |
| Manoj Kumar Gupta Also directs: Apur Medico Private Limited | Director | 15 Nov 2011 | 14 Years 11 Months | Current |
Peer Comparison of Unitab Pharmaceuticals Private Limited
Unitab Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nivova Pharmaceuticals Private Limited | ₹1.09 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Jabalpur, Madhya Pradesh, India |
| Henley Pharmaceuticals Private Limited | ₹1.09 Cr (FY 2022) | •••• | •••• | 87.0% | •••• | Salem, Tamil Nadu, India |
| Gudivaka Pharmaceuticals Private Limited | ₹1.09 Cr (FY 2022) | •••• | •••• | 1214.0% | •••• | Hyderabad, Telangana, India |
| Solvmax Laboratories Private Limited | ₹1.09 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Patna, Bihar, India |
| Novell Biolabs Private Limited | ₹1.09 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Bangalore, Karnataka, India |
| Unitab Pharmaceuticals Private Limited this company | ₹1.08 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Varanasi, Uttar Pradesh, India |
| Pious Medicare Private Limited | ₹1.08 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Meerut, Uttar Pradesh, India |
| Albero Pharma Private Limited | ₹1.08 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Valsad, Gujarat, India |
| 6Th Skin Pharmaceuticals Private Limited | ₹1.08 Cr (FY 2016) | •••• | •••• | 14.0% | •••• | Chennai, Tamil Nadu, India |
| Rach Lifecare Private Limited | ₹1.08 Cr (FY 2024) | •••• | •••• | 14.0% | •••• | Nagpur, Maharashtra, India |
| Shri Khatushyam Lifecare Private Limited | ₹1.08 Cr (FY 2024) | •••• | •••• | 90.0% | •••• | Jaipur, Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Unitab Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Unitab Pharmaceuticals Private Limited
Unitab Pharmaceuticals Private Limited is audited by SINGH BAJPAI & ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SINGH BAJPAI & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Unitab Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Unitab Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Mar 2012 | Indian Overseas Bank | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Unitab Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Unitab Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Unitab Pharmaceuticals Private Limited
Unitab Pharmaceuticals Private Limited has 4 board changes on record since 2011: 2 appointments and 2 cessations. The latest: Anjana Gupta was appointed as Director on 13 Feb 2014.
Credit Ratings, Litigation & Regulatory Alerts for Unitab Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Unitab Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Unitab Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Unitab Pharmaceuticals Private Limited
Unitab Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCU3713A1ZT | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Unitab Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Unitab Pharmaceuticals Private Limited
Unitab Pharmaceuticals is an active private limited company based in Varanasi, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 November 2011 (15+ years old) and is registered under CIN U52100UP2011PTC047423.
Unitab Pharmaceuticals reported revenue of ₹1.08 Cr for FY 2025 (down 7% YoY).
Unitab Pharmaceuticals has 2 current directors:
- Anjana Gupta - Director
- Manoj Kumar Gupta - Director
Unitab Pharmaceuticals reported a net profit of ₹1,177 (net margin 0%) and EBITDA of ₹4,277 (EBITDA margin 0%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Unitab Pharmaceuticals is 163% over five years. In the latest year (FY 2025) revenue fell 7%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Unitab Pharmaceuticals is 09AABCU3713A1ZT, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Unitab Pharmaceuticals is U52100UP2011PTC047423. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unitab Pharmaceuticals was incorporated on 15 November 2011, making it 15+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Unitab Pharmaceuticals by revenue are Nivova Pharmaceuticals Private Limited, Henley Pharmaceuticals Private Limited, Gudivaka Pharmaceuticals Private Limited, Solvmax Laboratories Private Limited, Novell Biolabs Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Anjana Gupta was appointed as Director on 13 Feb 2014. Munni Devi Gupta ceased to be Director on 13 Feb 2014. Rakesh Kumar Verma ceased to be Director on 01 May 2013. Unitab Pharmaceuticals has 4 board changes on record in total.
Unitab Pharmaceuticals can be reached through the website unitab.in. Its registered office is in Varanasi, Uttar Pradesh, India.